EA
AMAG

Emerald Acquisition’s AMAG Pharmaceuticals AMAG Stock Holding History

Emerald Acquisition’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$8.79M Sell
358,845
-80,233
-18% -$2.01M 0.02% 922
2016
Q2 		$10.5M Buy
+439,078
New +$10.1M 0.02% 904

Other funds holding AMAG

JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
SIM
Stelliam Investment Management New York $404M AUM 5.1% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Emerald Acquisition's AMAG Position: Q3 2016 in Review

Emerald Acquisition reduced its AMAG Pharmaceuticals (AMAG) stake by 18% in Q3 2016, selling an estimated $2.01M and leaving 358,845 shares worth $8.79M. The position accounts for 0.02% of the portfolio, ranked #922.

Emerald Acquisition first reported a position in AMAG in Q2 2016 and has held it in 2 quarters since. The position peaked at $10.5M in Q2 2016. 178 funds tracked by Wall St. Rank hold AMAG as of Q3 2016.

  • Emerald Acquisition held 358,845 shares of AMAG Pharmaceuticals worth $8.79M as of Q3 2016.
  • Emerald Acquisition sold 80,233 AMAG Pharmaceuticals shares in Q3 2016, an estimated $2.01M.
  • AMAG Pharmaceuticals made up 0.02% of Emerald Acquisition's portfolio in Q3 2016, its #922 holding.
  • Emerald Acquisition first reported a position in AMAG Pharmaceuticals in Q2 2016 and has held it in 2 quarters since.
  • Emerald Acquisition's AMAG Pharmaceuticals position peaked at $10.5M in Q2 2016.
  • 178 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.